This work is licensed under the Creative Commons Attribution 4.0 International License.
Nayerossadat N, Maedeh T, Ali P. Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 2012; 1: 27. doi:10.4103/2277-9175.98152NayerossadatNMaedehTAliP.Viral and nonviral delivery systems for gene delivery. Adv Biomed Res2012; 1: 27. 10.4103/2277-9175.98152Open DOISearch in Google Scholar
Lan T, Que H, Luo M, Zhao X, Wei X. Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy. Mol Cancer 2022; 21: 1-15. doi: 10.1186/s12943-022-01550-8LanTQueHLuoMZhaoXWeiX.Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy. Mol Cancer2022; 21: 1-15. 10.1186/s12943-022-01550-8Open DOISearch in Google Scholar
Miklavčič D, Mali B, Kos B, Heller R, Serša G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online 2014; 13: 29. doi: 10.1186/1475-925X-13-29MiklavčičDMaliBKosBHellerRSeršaG.Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online2014; 13: 29. 10.1186/1475-925X-13-29Open DOISearch in Google Scholar
Čemažar M, Miklavčič D, Serša G. Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res 1998; 89: 328-33. doi: 10.1111/j.1349-7006.1998.tb00566.xČemažarMMiklavčičDSeršaG.Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res1998; 89: 328-33. 10.1111/j.1349-7006.1998.tb00566.xOpen DOISearch in Google Scholar
Serša G, Novaković S, Miklavčič D. Potentiation of bleomycin antitumor effectiveness by electrotherapy. Cancer Lett 1993; 69: 81-4. doi: 10.1016/0304-3835(93)90159-7SeršaGNovakovićSMiklavčičD.Potentiation of bleomycin antitumor effectiveness by electrotherapy. Cancer Lett1993; 69: 81-4. 10.1016/0304-3835(93)90159-7Open DOISearch in Google Scholar
Neumann E, Rosenheck K. Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 1972; 10: 279-90. doi: 10.1007/BF01867861NeumannERosenheckK.Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol1972; 10: 279-90. 10.1007/BF01867861Open DOISearch in Google Scholar
Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83: 148-57. doi: 10.1002/(sici)1097-0142(19980701)83:1<148::aid-cncr20>3.0.co;2-wHellerRJaroszeskiMJReintgenDSPuleoCADeContiRCGilbertRATreatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer1998; 83: 148-57. 10.1002/(sici)1097-0142(19980701)83:1<148::aid-cncr20>3.0.co;2-wOpen DOISearch in Google Scholar
Vivod G, Jesenko T, Gasljevic G, Kovacevic N, Bosnjak M, Sersa G, et al. Treatment of vulvar cancer recurrences with electrochemotherapy - a detailed analysis of possible causes for unsuccessful treatment. Radiol Oncol 2023; 57: 121-6. doi: 10.2478/raon-2023-0010VivodGJesenkoTGasljevicGKovacevicNBosnjakMSersaGTreatment of vulvar cancer recurrences with electrochemotherapy - a detailed analysis of possible causes for unsuccessful treatment. Radiol Oncol2023; 57: 121-6. 10.2478/raon-2023-0010Open DOISearch in Google Scholar
Campana LG, Tauceri F, Bártolo J, Calabrese S, Odili J, Carrara G, et al. Treatment strategies with electrochemotherapy for limb in-transit melanoma: real-world outcomes from a European, retrospective, cohort study. Eur J Surg Oncol 2024; 5: 108740. doi: 10.1016/j.ejso.2024.108740CampanaLGTauceriFBártoloJCalabreseSOdiliJCarraraGTreatment strategies with electrochemotherapy for limb in-transit melanoma: real-world outcomes from a European retrospective, cohort study. Eur J Surg Oncol2024; 5: 108740. 10.1016/j.ejso.2024.108740Open DOISearch in Google Scholar
Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol 2018; 44: 651-7. doi: 10.1016/j. ejso.2018.01.090DjokicMCemazarMPopovicPKosBDezmanRBosnjakMElectrochemotherapy as treatment option for hepatocellular carcinoma a prospective pilot study. Eur J Surg Oncol2018; 44: 651-7. 10.1016/j. ejso.2018.01.090Open DOISearch in Google Scholar
Cemazar M, Jarm T, Sersa G. Cancer electrogene therapy with interleukin-12. Curr Gene Ther 2010; 10: 300-11. doi: 10.2174/156652310791823425CemazarMJarmTSersaG.Cancer electrogene therapy with interleukin-12. Curr Gene Ther2010; 10: 300-11. 10.2174/156652310791823425Open DOISearch in Google Scholar
Dolinsek T, Sersa G, Prosen L, Bosnjak M, Stimac M, Razborsek U, et al. Electrotransfer of plasmid DNA encoding an anti-mouse endoglin (CD105) shRNA to B16 melanoma tumors with low and high metastatic potential results in pronounced anti-tumor effects. Cancers 2015; 8: 3. doi: 10.3390/cancers8010003DolinsekTSersaGProsenLBosnjakMStimacMRazborsekUElectrotransfer of plasmid DNA encoding an anti-mouse endoglin (CD105) shRNA to B16 melanoma tumors with low and high metastatic potential results in pronounced anti-tumor effects. Cancers2015; 8: 3. 10.3390/cancers8010003Open DOISearch in Google Scholar
Bosnjak M, Dolinsek T, Cemazar M, Kranjc S, Blagus T, Markelc B, et al. Gene electrotransfer of plasmid AMEP, an integrin-targeted therapy, has antitumor and antiangiogenic action in murine B16 melanoma. Gene Ther 2015; 22: 578-90. doi: 10.1038/gt.2015.26BosnjakMDolinsekTCemazarMKranjcSBlagusTMarkelcBGene electrotransfer of plasmid AMEP an integrin-targeted therapy has antitumor and antiangiogenic action in murine B16 melanoma. Gene Ther2015; 22: 578-90. 10.1038/gt.2015.26Open DOISearch in Google Scholar
Kamensek U, Cemazar M, Lampreht Tratar U, Ursic K, Sersa G. Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model. Cancer Immunol Immunother 2018; 67: 785-95. doi: 10.1007/s00262-018-2133-0KamensekUCemazarMLampreht TratarUUrsicKSersaG.Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model. Cancer Immunol Immunother2018; 67: 785-95. 10.1007/s00262-018-2133-0Open DOISearch in Google Scholar
Rosazza C, Buntz A, Rieß T, Wöll D, Zumbusch A, Rols M-P. Intracellular tracking of single-plasmid DNA particles after delivery by electroporation. Mol Ther 2013; 21: 2217-26. doi: 10.1038/mt.2013.182RosazzaCBuntzARießTWöllDZumbuschARolsM-P.Intracellular tracking of single-plasmid DNA particles after delivery by electroporation. Mol Ther2013; 21: 2217-26. 10.1038/mt.2013.182Open DOISearch in Google Scholar
Komel T, Bosnjak M, Sersa G, Cemazar M. Expression of GFP and DsRed fluorescent proteins after gene electrotransfer of tumour cells in vitro. Bioelectrochemistry 2023; 153: 108490. doi: 10.1016/j.bioelech-em.2023.108490KomelTBosnjakMSersaGCemazarM.Expression of GFP and DsRed fluorescent proteins after gene electrotransfer of tumour cells in vitro. Bioelectrochemistry2023; 153: 108490. 10.1016/j.bioelech-em.2023.108490Open DOISearch in Google Scholar
Markelc B, Tevz G, Cemazar M, Kranjc S, Lavrencak J, Zegura B, et al. Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Therapy 2012; 19: 312-20. doi: 10.1038/gt.2011.97MarkelcBTevzGCemazarMKranjcSLavrencakJZeguraBMuscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Therapy2012; 19: 312-20. 10.1038/gt.2011.97Open DOISearch in Google Scholar
Tevz G, Pavlin D, Kamensek U, Kranjc S, Mesojednik S, Coer A, et al. Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression. Technol Cancer Res Treat 2008; 7: 91-101. doi: 10.1038/gt.2011.97TevzGPavlinDKamensekUKranjcSMesojednikSCoerAGene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression. Technol Cancer Res Treat2008; 7: 91-101. 10.1038/gt.2011.97Open DOISearch in Google Scholar
André FM, Gehl J, Sersa G, Préat V, Hojman P, Eriksen J, et al. Efficiency of high-and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther 2008; 19: 1261-72. doi: 10.1089/hum.2008.060AndréFMGehlJSersaGPréatVHojmanPEriksenJEfficiency of high-and low-voltage pulse combinations for gene electrotransfer in muscle liver, tumor, and skin. Hum Gene Ther2008; 19: 1261-72. 10.1089/hum.2008.060Open DOISearch in Google Scholar
Ursic K, Kos S, Kamensek U, Cemazar M, Miceska S, Markelc B, et al. Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. J Control Release 2021; 332: 623-35. doi: 10.1016/j.jconrel.2021.03.009UrsicKKosSKamensekUCemazarMMiceskaSMarkelcBPotentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. J Control Release2021; 332: 623-35. 10.1016/j.jconrel.2021.03.009Open DOISearch in Google Scholar
Sedlar A, Dolinsek T, Markelc B, Prosen L, Kranjc S, Bosnjak M, et al. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol 2012; 46: 302-11. doi: 10.2478/v10019-012-0044-9SedlarADolinsekTMarkelcBProsenLKranjcSBosnjakMPotentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol2012; 46: 302-11. 10.2478/v10019-012-0044-9Open DOISearch in Google Scholar
Smith AJ, Clutton RE, Lilley E, Hansen KEA, Brattelid T. PREPARE: guidelines for planning animal research and testing. Lab Anim 2018; 52: 135-141. doi: 10.1177/0023677217724823SmithAJCluttonRELilleyEHansenKEABrattelidT.PREPARE: guidelines for planning animal research and testing. Lab Anim2018; 52: 135-141. 10.1177/0023677217724823Open DOISearch in Google Scholar
De Vleeschauwer SI, van de Ven M, Oudin A, Debusschere K, Connor K, Byrne AT, et al. OBSERVE: guidelines for the refinement of rodent cancer models. Nat Protoc 2024; 19: 2571-2596. doi: 10.1038/s41596-024-00998-wDe VleeschauwerSIvan de VenMOudinADebusschereKConnorKByrneATOBSERVE: guidelines for the refinement of rodent cancer models. Nat Protoc2024; 19: 2571-2596. 10.1038/s41596-024-00998-wOpen DOISearch in Google Scholar
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 2020; 18: e3000410. doi: 10.1371/journal.pbio.3000410Percie du SertNHurstVAhluwaliaAAlamSAveyMTBakerMThe ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol2020; 18: e3000410. 10.1371/journal.pbio.3000410Open DOISearch in Google Scholar
Cemazar M, Golzio M, Sersa G, Escoffre JM, Coer A, Vidic S, et al. Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors. Hum Gene Ther 2011; 23: 128. doi: 10.1089/hum.2011.073CemazarMGolzioMSersaGEscoffreJMCoerAVidicSHyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors. Hum Gene Ther2011; 23: 128. 10.1089/hum.2011.073Open DOISearch in Google Scholar
Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602GehlJSersaGMatthiessenLWMuirTSodenDOcchiniAUpdated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol2018; 57: 874-82. 10.1080/0284186X.2018.1454602Open DOISearch in Google Scholar
Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Supp 2006; 4: 3-13. doi: 10.1016/j.ejcsup.2006.08.002MartyMSersaGGarbayJRGehlJCollinsCGSnojMElectrochemotherapy – an easy highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Supp2006; 4: 3-13. 10.1016/j.ejcsup.2006.08.002Open DOISearch in Google Scholar
Cvetkoska A, Maček-Lebar A, Trdina P, Miklavčič D, Reberšek M. Muscle contractions and pain sensation accompanying high-frequency electroporation pulses. Sci Rep 2022; 12: 1-15. doi: 10.1038/s41598-022-12112-9CvetkoskaAMaček-LebarATrdinaPMiklavčičDReberšekM.Muscle contractions and pain sensation accompanying high-frequency electroporation pulses. Sci Rep2022; 12: 1-15. 10.1038/s41598-022-12112-9Open DOISearch in Google Scholar
Scuderi M, Dermol-Cerne J, Scancar J, Markovic S, Rems L, Miklavcic D, et al. The equivalence of different types of electric pulses for electrochemotherapy with cisplatin – an in vitro study. Radiol Oncol 2024; 58: 51-66. doi: 10.2478/raon-2024-0005ScuderiMDermol-CerneJScancarJMarkovicSRemsLMiklavcicDThe equivalence of different types of electric pulses for electrochemotherapy with cisplatin – an in vitro study. Radiol Oncol2024; 58: 51-66. 10.2478/raon-2024-0005Open DOISearch in Google Scholar
Sano MB, Fan RE, Cheng K, Saenz Y, Sonn GA, Hwang GL, et al. Reduction of muscle contractions during irreversible electroporation therapy using high-frequency bursts of alternating polarity pulses: a laboratory investigation in an ex vivo swine model. J Vasc Interv Radiol 2018; 29: 893-8.e4. doi: 10.5306/wjco.v12.i5.367SanoMBFanREChengKSaenzYSonnGAHwangGLReduction of muscle contractions during irreversible electroporation therapy using high-frequency bursts of alternating polarity pulses: a laboratory investigation in an ex vivo swine model. J Vasc Interv Radiol2018; 29: 893-8.e4. 10.5306/wjco.v12.i5.367Open DOISearch in Google Scholar
Znidar K, Bosnjak M, Cemazar M, Heller LCLC. Cytosolic DNA sensor upregulation accompanies DNA electrotransfer in B16.F10 melanoma cells. Mol Ther Nucl Acids 2016; 5: e322. doi: 10.1038/mtna.2016.34ZnidarKBosnjakMCemazarMHellerLCLC.Cytosolic DNA sensor upregulation accompanies DNA electrotransfer in B16.F10 melanoma cells. Mol Ther Nucl Acids2016; 5: e322. 10.1038/mtna.2016.34Open DOISearch in Google Scholar
Znidar K, Bosnjak M, Heller LC, Čemažar M. Electrostransfer of plasmid gWIZ blank into B16-F10 and TS/A increase expression of cytosolic DNA PRRs. In: IFMBE Proceedings. 2016; 53: 183. doi: 10.1007/978-981-287-817-5_41ZnidarKBosnjakMHellerLCČemažarM.Electrostransfer of plasmid gWIZ blank into B16-F10 and TS/A increase expression of cytosolic DNA PRRs. In: IFMBE Proceedings. 2016; 53: 183. 10.1007/978-981-287-817-5_41Open DOISearch in Google Scholar
Semenova N, Bosnjak M, Markelc B, Znidar K, Cemazar M, Heller L. Multiple cytosolic DNA sensors bind plasmid DNA after transfection. Nucleic Acids Res 2019; 47: 10235-46. doi: 10.1093/nar/gkz768SemenovaNBosnjakMMarkelcBZnidarKCemazarMHellerL.Multiple cytosolic DNA sensors bind plasmid DNA after transfection. Nucleic Acids Res2019; 47: 10235-46. 10.1093/nar/gkz768Open DOISearch in Google Scholar
Bosnjak M, Jesenko T, Kamensek U, Sersa G, Lavrencak J, Heller L, et al. Electrotransfer of different control plasmids elicits different antitumor effectiveness in B16.F10 melanoma. Cancers 2018; 10: 37. doi: 10.3390/cancers10020037BosnjakMJesenkoTKamensekUSersaGLavrencakJHellerLElectrotransfer of different control plasmids elicits different antitumor effectiveness in B16.F10 melanoma. Cancers2018; 10: 37. 10.3390/cancers10020037Open DOISearch in Google Scholar
Bosnjak M, Lorente BC, Pogacar Z, Makovsek V, Cemazar M. Different incubation times of cells after gene electrotransfer in fetal bovine serum affect cell viability, but not transfection efficiency. J Memb Biol 2014; 247: 421-8. doi: 10.1007/s00232-014-9649-9BosnjakMLorenteBCPogacarZMakovsekVCemazarM.Different incubation times of cells after gene electrotransfer in fetal bovine serum affect cell viability, but not transfection efficiency. J Memb Biol2014; 247: 421-8. 10.1007/s00232-014-9649-9Open DOISearch in Google Scholar
Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315-27. doi: 10.1007/s00262-015-1724-2SersaGTeissieJCemazarMSignoriEKamensekUMarshallGElectrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother2015; 64: 1315-27. 10.1007/s00262-015-1724-2Open DOISearch in Google Scholar
Kos S, Bosnjak M, Jesenko T, Markelc B, Kamensek U, Znidar K, et al. Non-clinical in vitro evaluation of antibiotic resistance gene-free plasmids encoding human or murine IL-12 intended for first-in-human clinical study. Pharmaceutics 2021; 13: 1739. doi: 10.3390/pharmaceutics13101739KosSBosnjakMJesenkoTMarkelcBKamensekUZnidarKNon-clinical in vitro evaluation of antibiotic resistance gene-free plasmids encoding human or murine IL-12 intended for first-in-human clinical study. Pharmaceutics2021; 13: 1739. 10.3390/pharmaceutics13101739Open DOISearch in Google Scholar
Markelc B, Jesenko T, Kranjc Brezar S, Omerzel M, Lampreht Tratar U, Rencelj A, et al. Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study. Sci Rep 2024; 14: 22288. doi: 10.1038/s41598-024-73314-xMarkelcBJesenkoTKranjc BrezarSOmerzelMLampreht TratarURenceljANon-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study. Sci Rep2024; 14: 22288. 10.1038/s41598-024-73314-xOpen DOISearch in Google Scholar
Strojan P, Jesenko T, Omerzel M, Jamsek C, Groselj A, Tratar UL, et al. Phase I trial of phIL12 plasmid intratumoral gene electrotransfer in patients with basal cell carcinoma in head and neck region. Eur J Surg Oncol 2025; 51:109574. doi: 10.1016/j.ejso.2025.109574StrojanPJesenkoTOmerzelMJamsekCGroseljATratarULPhase I trial of phIL12 plasmid intratumoral gene electrotransfer in patients with basal cell carcinoma in head and neck region. Eur J Surg Oncol2025; 51:109574. 10.1016/j.ejso.2025.109574Open DOISearch in Google Scholar
Lampreht Tratar U, Jesenko T, Omerzel M, Seliskar A, Stupan U, Djokic M, et al. Safety and efficacy of IL-12 plasmid DNA transfection into pig skin: supportive data for human clinical trials on gene therapy and vaccination. Int J Mol Sci 2024; 25: 3151. doi: 10.3390/IJMS25063151Lampreht TratarUJesenkoTOmerzelMSeliskarAStupanUDjokicMSafety and efficacy of IL-12 plasmid DNA transfection into pig skin: supportive data for human clinical trials on gene therapy and vaccination. Int J Mol Sci2024; 25: 3151. 10.3390/IJMS25063151Open DOISearch in Google Scholar
Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30–40. doi: 10.1016/j.ejca.2020.06.020CloverAJPde TerlizziFBertinoGCuratoloPOdiliJCampanaLGElectrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer2020; 138: 30–40. 10.1016/j.ejca.2020.06.020Open DOISearch in Google Scholar
Conniff AS, Tur J, Kohena K, Zhang M, Gibbons J, Heller LC. DNA electrotransfer regulates molecular functions in skeletal muscle. Bioelectricity 2024; 6: 80-90. doi: 10.1089/bioe.2022.0041ConniffASTurJKohenaKZhangMGibbonsJHellerLC.DNA electrotransfer regulates molecular functions in skeletal muscle. Bioelectricity2024; 6: 80-90. 10.1089/bioe.2022.0041Open DOISearch in Google Scholar
Spanggaard I, Dahlstroem K, Laessoee L, Hansen RH, Johannesen HH, Hendel HW, et al. Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP. Acta Oncol 2017; 56: 909-16. doi: 10.1080/0284186X.2017.1315171SpanggaardIDahlstroemKLaessoeeLHansenRHJohannesenHHHendelHWGene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP. Acta Oncol2017; 56: 909-16. 10.1080/0284186X.2017.1315171Open DOISearch in Google Scholar
Aurisicchio L, Brambilla N, Cazzaniga ME, Bonfanti P, Milleri S, Ascierto PA, et al. A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19. Mol Ther 2022; 31: 788. doi: 10.1016/j.ymthe.2022.12.017AurisicchioLBrambillaNCazzanigaMEBonfantiPMilleriSAsciertoPAA first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19. Mol Ther2022; 31: 788. 10.1016/j.ymthe.2022.12.017Open DOISearch in Google Scholar
Lampreht Tratar U, Milevoj N, Cemazar M, Znidar K, Ursic Valentinuzzi K, Brozic A, et al. Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: comparison of intratumoral and peritumoral application of IL-12. Int Immunopharmacol 2023; 120: 110274. doi: 10.1016/j.intimp.2023.110274Lampreht TratarUMilevojNCemazarMZnidarKUrsic ValentinuzziKBrozicATreatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: comparison of intratumoral and peritumoral application of IL-12. Int Immunopharmacol2023; 120: 110274. 10.1016/j.intimp.2023.110274Open DOISearch in Google Scholar
Clover AJP, Bertino G, Curatolo P, Odili J, Campana L, Kunte C, et al. Electrochemotherapy in the treatment of cutaneous malignancy; outcomes and subgroup analysis from the cumulative results from the pan-European InspECT Database for 1478 lesions in 691 patients (2008-2018). Eur J Cancer 2020; 138: 30-40. doi: 10.1016/j.ejso.2018.10.090.CloverAJPBertinoGCuratoloPOdiliJCampanaLKunteCElectrochemotherapy in the treatment of cutaneous malignancy; outcomes and subgroup analysis from the cumulative results from the pan-European InspECT Database for 1478 lesions in 691 patients (2008-2018). Eur J Cancer2020; 138: 30-40. 10.1016/j.ejso.2018.10.090.Open DOISearch in Google Scholar